BIONIK LABORATORIES CORP.: 10-Q filed 2012-11-19

Name: BIONIK LABORATORIES CORP.: 10-Q filed 2012-11-19
Creator: BIONIK LABORATORIES CORP.

What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2012-11-19 (fiscal Q3 2012): 17 published measures, 55 facts as tagged in accession 0001014897-12-000396.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-11-19
Fiscal period: fiscal Q3 2012
Accession: 0001014897-12-000396 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-09-30	15,568	USD
At 2011-12-31	12,455	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-09-30	8,963	USD
At 2011-12-31	6,123	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,051	USD	92
2012-01-01 to 2012-09-30	2,840	USD	274
2010-01-08 to 2012-09-30	-9,687	USD	997
2011-07-01 to 2011-09-30	1,290	USD	92
2011-01-01 to 2011-09-30	90	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	3,113	USD	274
2010-01-08 to 2012-09-30	-8,282	USD	997
2011-01-01 to 2011-09-30	180	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	0	USD	274
2010-01-08 to 2012-09-30	23,850	USD	997
2011-01-01 to 2011-09-30	0	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Unit	Days
2012-01-01 to 2012-09-30	USD	274
2010-01-08 to 2012-09-30	USD	997
2011-01-01 to 2011-09-30	USD	273

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	4,988,500	shares	92
2012-01-01 to 2012-09-30	4,988,500	shares	274
2011-07-01 to 2011-09-30	4,900,000	shares	92
2011-01-01 to 2011-09-30	4,900,000	shares	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-09-30	15,568	USD
At 2011-12-31	12,455	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-90	USD	92
2012-01-01 to 2012-09-30	-273	USD	274
2010-01-08 to 2012-09-30	-455	USD	997
2011-07-01 to 2011-09-30	-90	USD	92
2011-01-01 to 2011-09-30	-90	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-09-30	6,332	USD
At 2011-12-31	6,332	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	359	USD	92
2012-01-01 to 2012-09-30	3,887	USD	274
2010-01-08 to 2012-09-30	30,136	USD	997
2011-07-01 to 2011-09-30	2,120	USD	92
2011-01-01 to 2011-09-30	5,320	USD	273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-09-30	13,661	USD
At 2011-12-31	13,661	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	359	USD	92
2012-01-01 to 2012-09-30	3,887	USD	274
2010-01-08 to 2012-09-30	30,136	USD	997
2011-07-01 to 2011-09-30	2,120	USD	92
2011-01-01 to 2011-09-30	5,320	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Unit	Days
2012-01-01 to 2012-09-30	USD	274
2010-01-08 to 2012-09-30	USD	997
2011-01-01 to 2011-09-30	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Unit	Days
2012-01-01 to 2012-09-30	USD	274
2010-01-08 to 2012-09-30	USD	997
2011-01-01 to 2011-09-30	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	0	USD	274
2010-01-08 to 2012-09-30	17,850	USD	997
2011-01-01 to 2011-09-30	0	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	0	USD	274
2010-01-08 to 2012-09-30	-79	USD	997
2011-01-01 to 2011-09-30	0	USD	273

Inspect the source

Entity: BIONIK LABORATORIES CORP. / CIK 0001508381
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))